Global Immunochemicals

Immunochemicals Comprehensive Study by Type (Custom monoclonal antibodies, Custom polyclonal antibodies, Custom AB fragments, Catalogue antibodies, Others), Application (Healthcare, Environmental Science, Crop Protection and Biotechnology, Other), Prodcuts (CD4, LEU3, CD8a, CD44, Ly6g, IFN Gamma, CD69, CD19, FOXP3, CD14, EPCAM, Ly5, Others), Sales Channel (Direct Sales, E-Commerce) Players and Region - Global Market Outlook to 2026

Immunochemicals Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Immunochemistry deals with the study of biochemical and molecular aspects of immunology, especially the character of antibodies, antigens and their interactions. Immunochemistry is the field of life sciences that examines the chemical reactions and components of the immune system. Immunochemicals find their usage in diagnostics, laboratory medicine, immunological reactions, and investigations as well as in the field of immunochemistry examination. Immunochemicals are used to study the reactions and components of the immune system and include growth factors, hormones, and their receptors, markers of metabolism, mono- and polyclonal antibodies, and antigens. Applications for immunochemical include antibody purification, isotyping, and fragmentationThis growth is primarily driven by The Rise in the Number of Patients Suffering From Various Types of Chronic Diseases and Increase in Research and Development Activities Sponsored By the Government of Various Countries.

Globally, a noticeable market trend is evident Rising Applications of Immunochemicals in Life Sciences. Major Players, such as Thermo Fisher Scientific (United States), Abcam Plc. (United Kingdom), Agilent Research Laboratories (United States, Roche Holding AG (Switzerland), Otsuka Pharmaceutical (Japan), Beckman Coulter GmbH (United States), Biolegend, Inc. (United States), Bio-Rad Laboratories (United States), Cell Signaling Technology (United States) and GenScript Biotech Corporation (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

In January 2019, Sanofi signed an agreement with French biopharmaceutical firm, Biomunex Pharmaceuticals for the development of antibody-based drugs and In July 2018, Otsuka Pharmaceutical acquired privately-held US biotech Visterra for its expansion in the United States.

Market Drivers
  • The Rise in the Number of Patients Suffering From Various Types of Chronic Diseases
  • Increase in Research and Development Activities Sponsored By the Government of Various Countries

Market Trend
  • Rising Applications of Immunochemicals in Life Sciences

Restraints
  • High Cost Incurred In the Production of the Immunochemical

Opportunities
There Is an Increased Opportunity for Healthcare Companies for Their Market Expansion and Prospects in Development of New and More Effective Immunochemical
Challenges
Stringent Government Regulations in the Production of Immunochemicals and Developing Immunochemical That Produces Minimum Side Effects

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Immunochemicals Study Sheds Light on
— The Immunochemicals Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Immunochemicals industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Immunochemicals industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Custom monoclonal antibodies
  • Custom polyclonal antibodies
  • Custom AB fragments
  • Catalogue antibodies
  • Others
By Application
  • Healthcare
  • Environmental Science
  • Crop Protection and Biotechnology
  • Other
By Prodcuts
  • CD4
  • LEU3
  • CD8a
  • CD44
  • Ly6g
  • IFN Gamma
  • CD69
  • CD19
  • FOXP3
  • CD14
  • EPCAM
  • Ly5
  • Others

By Sales Channel
  • Direct Sales
  • E-Commerce

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Rise in the Number of Patients Suffering From Various Types of Chronic Diseases
      • 3.2.2. Increase in Research and Development Activities Sponsored By the Government of Various Countries
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Regulations in the Production of Immunochemicals
      • 3.3.2. Developing Immunochemical That Produces Minimum Side Effects
    • 3.4. Market Trends
      • 3.4.1. Rising Applications of Immunochemicals in Life Sciences
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Immunochemicals, by Type, Application, Prodcuts, Sales Channel and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Immunochemicals (Value)
      • 5.2.1. Global Immunochemicals by: Type (Value)
        • 5.2.1.1. Custom monoclonal antibodies
        • 5.2.1.2. Custom polyclonal antibodies
        • 5.2.1.3. Custom AB fragments
        • 5.2.1.4. Catalogue antibodies
        • 5.2.1.5. Others
      • 5.2.2. Global Immunochemicals by: Application (Value)
        • 5.2.2.1. Healthcare
        • 5.2.2.2. Environmental Science
        • 5.2.2.3. Crop Protection and Biotechnology
        • 5.2.2.4. Other
      • 5.2.3. Global Immunochemicals by: Prodcuts (Value)
        • 5.2.3.1. CD4
        • 5.2.3.2. LEU3
        • 5.2.3.3. CD8a
        • 5.2.3.4. CD44
        • 5.2.3.5. Ly6g
        • 5.2.3.6. IFN Gamma
        • 5.2.3.7. CD69
        • 5.2.3.8. CD19
        • 5.2.3.9. FOXP3
        • 5.2.3.10. CD14
        • 5.2.3.11. EPCAM
        • 5.2.3.12. Ly5
        • 5.2.3.13. Others
      • 5.2.4. Global Immunochemicals by: Sales Channel (Value)
        • 5.2.4.1. Direct Sales
        • 5.2.4.2. E-Commerce
      • 5.2.5. Global Immunochemicals Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Immunochemicals (Volume)
      • 5.3.1. Global Immunochemicals by: Type (Volume)
        • 5.3.1.1. Custom monoclonal antibodies
        • 5.3.1.2. Custom polyclonal antibodies
        • 5.3.1.3. Custom AB fragments
        • 5.3.1.4. Catalogue antibodies
        • 5.3.1.5. Others
      • 5.3.2. Global Immunochemicals by: Application (Volume)
        • 5.3.2.1. Healthcare
        • 5.3.2.2. Environmental Science
        • 5.3.2.3. Crop Protection and Biotechnology
        • 5.3.2.4. Other
      • 5.3.3. Global Immunochemicals by: Prodcuts (Volume)
        • 5.3.3.1. CD4
        • 5.3.3.2. LEU3
        • 5.3.3.3. CD8a
        • 5.3.3.4. CD44
        • 5.3.3.5. Ly6g
        • 5.3.3.6. IFN Gamma
        • 5.3.3.7. CD69
        • 5.3.3.8. CD19
        • 5.3.3.9. FOXP3
        • 5.3.3.10. CD14
        • 5.3.3.11. EPCAM
        • 5.3.3.12. Ly5
        • 5.3.3.13. Others
      • 5.3.4. Global Immunochemicals by: Sales Channel (Volume)
        • 5.3.4.1. Direct Sales
        • 5.3.4.2. E-Commerce
      • 5.3.5. Global Immunochemicals Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Immunochemicals (Price)
      • 5.4.1. Global Immunochemicals by: Type (Price)
  • 6. Immunochemicals: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abcam Plc. (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Agilent Research Laboratories (United States
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Roche Holding AG (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Otsuka Pharmaceutical (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Beckman Coulter GmbH (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Biolegend, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bio-Rad Laboratories (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Cell Signaling Technology (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. GenScript Biotech Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Immunochemicals Sale, by Type, Application, Prodcuts, Sales Channel and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Immunochemicals (Value)
      • 7.2.1. Global Immunochemicals by: Type (Value)
        • 7.2.1.1. Custom monoclonal antibodies
        • 7.2.1.2. Custom polyclonal antibodies
        • 7.2.1.3. Custom AB fragments
        • 7.2.1.4. Catalogue antibodies
        • 7.2.1.5. Others
      • 7.2.2. Global Immunochemicals by: Application (Value)
        • 7.2.2.1. Healthcare
        • 7.2.2.2. Environmental Science
        • 7.2.2.3. Crop Protection and Biotechnology
        • 7.2.2.4. Other
      • 7.2.3. Global Immunochemicals by: Prodcuts (Value)
        • 7.2.3.1. CD4
        • 7.2.3.2. LEU3
        • 7.2.3.3. CD8a
        • 7.2.3.4. CD44
        • 7.2.3.5. Ly6g
        • 7.2.3.6. IFN Gamma
        • 7.2.3.7. CD69
        • 7.2.3.8. CD19
        • 7.2.3.9. FOXP3
        • 7.2.3.10. CD14
        • 7.2.3.11. EPCAM
        • 7.2.3.12. Ly5
        • 7.2.3.13. Others
      • 7.2.4. Global Immunochemicals by: Sales Channel (Value)
        • 7.2.4.1. Direct Sales
        • 7.2.4.2. E-Commerce
      • 7.2.5. Global Immunochemicals Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Immunochemicals (Volume)
      • 7.3.1. Global Immunochemicals by: Type (Volume)
        • 7.3.1.1. Custom monoclonal antibodies
        • 7.3.1.2. Custom polyclonal antibodies
        • 7.3.1.3. Custom AB fragments
        • 7.3.1.4. Catalogue antibodies
        • 7.3.1.5. Others
      • 7.3.2. Global Immunochemicals by: Application (Volume)
        • 7.3.2.1. Healthcare
        • 7.3.2.2. Environmental Science
        • 7.3.2.3. Crop Protection and Biotechnology
        • 7.3.2.4. Other
      • 7.3.3. Global Immunochemicals by: Prodcuts (Volume)
        • 7.3.3.1. CD4
        • 7.3.3.2. LEU3
        • 7.3.3.3. CD8a
        • 7.3.3.4. CD44
        • 7.3.3.5. Ly6g
        • 7.3.3.6. IFN Gamma
        • 7.3.3.7. CD69
        • 7.3.3.8. CD19
        • 7.3.3.9. FOXP3
        • 7.3.3.10. CD14
        • 7.3.3.11. EPCAM
        • 7.3.3.12. Ly5
        • 7.3.3.13. Others
      • 7.3.4. Global Immunochemicals by: Sales Channel (Volume)
        • 7.3.4.1. Direct Sales
        • 7.3.4.2. E-Commerce
      • 7.3.5. Global Immunochemicals Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Immunochemicals (Price)
      • 7.4.1. Global Immunochemicals by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Immunochemicals: by Type(USD Million)
  • Table 2. Immunochemicals Custom monoclonal antibodies , by Region USD Million (2015-2020)
  • Table 3. Immunochemicals Custom polyclonal antibodies , by Region USD Million (2015-2020)
  • Table 4. Immunochemicals Custom AB fragments , by Region USD Million (2015-2020)
  • Table 5. Immunochemicals Catalogue antibodies , by Region USD Million (2015-2020)
  • Table 6. Immunochemicals Others , by Region USD Million (2015-2020)
  • Table 7. Immunochemicals: by Application(USD Million)
  • Table 8. Immunochemicals Healthcare , by Region USD Million (2015-2020)
  • Table 9. Immunochemicals Environmental Science , by Region USD Million (2015-2020)
  • Table 10. Immunochemicals Crop Protection and Biotechnology , by Region USD Million (2015-2020)
  • Table 11. Immunochemicals Other , by Region USD Million (2015-2020)
  • Table 12. Immunochemicals: by Prodcuts(USD Million)
  • Table 13. Immunochemicals CD4 , by Region USD Million (2015-2020)
  • Table 14. Immunochemicals LEU3 , by Region USD Million (2015-2020)
  • Table 15. Immunochemicals CD8a , by Region USD Million (2015-2020)
  • Table 16. Immunochemicals CD44 , by Region USD Million (2015-2020)
  • Table 17. Immunochemicals Ly6g , by Region USD Million (2015-2020)
  • Table 18. Immunochemicals IFN Gamma , by Region USD Million (2015-2020)
  • Table 19. Immunochemicals CD69 , by Region USD Million (2015-2020)
  • Table 20. Immunochemicals CD19 , by Region USD Million (2015-2020)
  • Table 21. Immunochemicals FOXP3 , by Region USD Million (2015-2020)
  • Table 22. Immunochemicals CD14 , by Region USD Million (2015-2020)
  • Table 23. Immunochemicals EPCAM , by Region USD Million (2015-2020)
  • Table 24. Immunochemicals Ly5 , by Region USD Million (2015-2020)
  • Table 25. Immunochemicals Others , by Region USD Million (2015-2020)
  • Table 26. Immunochemicals: by Sales Channel(USD Million)
  • Table 27. Immunochemicals Direct Sales , by Region USD Million (2015-2020)
  • Table 28. Immunochemicals E-Commerce , by Region USD Million (2015-2020)
  • Table 29. South America Immunochemicals, by Country USD Million (2015-2020)
  • Table 30. South America Immunochemicals, by Type USD Million (2015-2020)
  • Table 31. South America Immunochemicals, by Application USD Million (2015-2020)
  • Table 32. South America Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 33. South America Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 34. Brazil Immunochemicals, by Type USD Million (2015-2020)
  • Table 35. Brazil Immunochemicals, by Application USD Million (2015-2020)
  • Table 36. Brazil Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 37. Brazil Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 38. Argentina Immunochemicals, by Type USD Million (2015-2020)
  • Table 39. Argentina Immunochemicals, by Application USD Million (2015-2020)
  • Table 40. Argentina Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 41. Argentina Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 42. Rest of South America Immunochemicals, by Type USD Million (2015-2020)
  • Table 43. Rest of South America Immunochemicals, by Application USD Million (2015-2020)
  • Table 44. Rest of South America Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 45. Rest of South America Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 46. Asia Pacific Immunochemicals, by Country USD Million (2015-2020)
  • Table 47. Asia Pacific Immunochemicals, by Type USD Million (2015-2020)
  • Table 48. Asia Pacific Immunochemicals, by Application USD Million (2015-2020)
  • Table 49. Asia Pacific Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 50. Asia Pacific Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 51. China Immunochemicals, by Type USD Million (2015-2020)
  • Table 52. China Immunochemicals, by Application USD Million (2015-2020)
  • Table 53. China Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 54. China Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 55. Japan Immunochemicals, by Type USD Million (2015-2020)
  • Table 56. Japan Immunochemicals, by Application USD Million (2015-2020)
  • Table 57. Japan Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 58. Japan Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 59. India Immunochemicals, by Type USD Million (2015-2020)
  • Table 60. India Immunochemicals, by Application USD Million (2015-2020)
  • Table 61. India Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 62. India Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 63. South Korea Immunochemicals, by Type USD Million (2015-2020)
  • Table 64. South Korea Immunochemicals, by Application USD Million (2015-2020)
  • Table 65. South Korea Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 66. South Korea Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 67. Taiwan Immunochemicals, by Type USD Million (2015-2020)
  • Table 68. Taiwan Immunochemicals, by Application USD Million (2015-2020)
  • Table 69. Taiwan Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 70. Taiwan Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 71. Australia Immunochemicals, by Type USD Million (2015-2020)
  • Table 72. Australia Immunochemicals, by Application USD Million (2015-2020)
  • Table 73. Australia Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 74. Australia Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 75. Rest of Asia-Pacific Immunochemicals, by Type USD Million (2015-2020)
  • Table 76. Rest of Asia-Pacific Immunochemicals, by Application USD Million (2015-2020)
  • Table 77. Rest of Asia-Pacific Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 78. Rest of Asia-Pacific Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 79. Europe Immunochemicals, by Country USD Million (2015-2020)
  • Table 80. Europe Immunochemicals, by Type USD Million (2015-2020)
  • Table 81. Europe Immunochemicals, by Application USD Million (2015-2020)
  • Table 82. Europe Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 83. Europe Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 84. Germany Immunochemicals, by Type USD Million (2015-2020)
  • Table 85. Germany Immunochemicals, by Application USD Million (2015-2020)
  • Table 86. Germany Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 87. Germany Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 88. France Immunochemicals, by Type USD Million (2015-2020)
  • Table 89. France Immunochemicals, by Application USD Million (2015-2020)
  • Table 90. France Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 91. France Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 92. Italy Immunochemicals, by Type USD Million (2015-2020)
  • Table 93. Italy Immunochemicals, by Application USD Million (2015-2020)
  • Table 94. Italy Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 95. Italy Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 96. United Kingdom Immunochemicals, by Type USD Million (2015-2020)
  • Table 97. United Kingdom Immunochemicals, by Application USD Million (2015-2020)
  • Table 98. United Kingdom Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 99. United Kingdom Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 100. Netherlands Immunochemicals, by Type USD Million (2015-2020)
  • Table 101. Netherlands Immunochemicals, by Application USD Million (2015-2020)
  • Table 102. Netherlands Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 103. Netherlands Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 104. Rest of Europe Immunochemicals, by Type USD Million (2015-2020)
  • Table 105. Rest of Europe Immunochemicals, by Application USD Million (2015-2020)
  • Table 106. Rest of Europe Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 107. Rest of Europe Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 108. MEA Immunochemicals, by Country USD Million (2015-2020)
  • Table 109. MEA Immunochemicals, by Type USD Million (2015-2020)
  • Table 110. MEA Immunochemicals, by Application USD Million (2015-2020)
  • Table 111. MEA Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 112. MEA Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 113. Middle East Immunochemicals, by Type USD Million (2015-2020)
  • Table 114. Middle East Immunochemicals, by Application USD Million (2015-2020)
  • Table 115. Middle East Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 116. Middle East Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 117. Africa Immunochemicals, by Type USD Million (2015-2020)
  • Table 118. Africa Immunochemicals, by Application USD Million (2015-2020)
  • Table 119. Africa Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 120. Africa Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 121. North America Immunochemicals, by Country USD Million (2015-2020)
  • Table 122. North America Immunochemicals, by Type USD Million (2015-2020)
  • Table 123. North America Immunochemicals, by Application USD Million (2015-2020)
  • Table 124. North America Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 125. North America Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 126. United States Immunochemicals, by Type USD Million (2015-2020)
  • Table 127. United States Immunochemicals, by Application USD Million (2015-2020)
  • Table 128. United States Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 129. United States Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 130. Canada Immunochemicals, by Type USD Million (2015-2020)
  • Table 131. Canada Immunochemicals, by Application USD Million (2015-2020)
  • Table 132. Canada Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 133. Canada Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 134. Mexico Immunochemicals, by Type USD Million (2015-2020)
  • Table 135. Mexico Immunochemicals, by Application USD Million (2015-2020)
  • Table 136. Mexico Immunochemicals, by Prodcuts USD Million (2015-2020)
  • Table 137. Mexico Immunochemicals, by Sales Channel USD Million (2015-2020)
  • Table 138. Immunochemicals Sales: by Type(K Units)
  • Table 139. Immunochemicals Sales Custom monoclonal antibodies , by Region K Units (2015-2020)
  • Table 140. Immunochemicals Sales Custom polyclonal antibodies , by Region K Units (2015-2020)
  • Table 141. Immunochemicals Sales Custom AB fragments , by Region K Units (2015-2020)
  • Table 142. Immunochemicals Sales Catalogue antibodies , by Region K Units (2015-2020)
  • Table 143. Immunochemicals Sales Others , by Region K Units (2015-2020)
  • Table 144. Immunochemicals Sales: by Application(K Units)
  • Table 145. Immunochemicals Sales Healthcare , by Region K Units (2015-2020)
  • Table 146. Immunochemicals Sales Environmental Science , by Region K Units (2015-2020)
  • Table 147. Immunochemicals Sales Crop Protection and Biotechnology , by Region K Units (2015-2020)
  • Table 148. Immunochemicals Sales Other , by Region K Units (2015-2020)
  • Table 149. Immunochemicals Sales: by Prodcuts(K Units)
  • Table 150. Immunochemicals Sales CD4 , by Region K Units (2015-2020)
  • Table 151. Immunochemicals Sales LEU3 , by Region K Units (2015-2020)
  • Table 152. Immunochemicals Sales CD8a , by Region K Units (2015-2020)
  • Table 153. Immunochemicals Sales CD44 , by Region K Units (2015-2020)
  • Table 154. Immunochemicals Sales Ly6g , by Region K Units (2015-2020)
  • Table 155. Immunochemicals Sales IFN Gamma , by Region K Units (2015-2020)
  • Table 156. Immunochemicals Sales CD69 , by Region K Units (2015-2020)
  • Table 157. Immunochemicals Sales CD19 , by Region K Units (2015-2020)
  • Table 158. Immunochemicals Sales FOXP3 , by Region K Units (2015-2020)
  • Table 159. Immunochemicals Sales CD14 , by Region K Units (2015-2020)
  • Table 160. Immunochemicals Sales EPCAM , by Region K Units (2015-2020)
  • Table 161. Immunochemicals Sales Ly5 , by Region K Units (2015-2020)
  • Table 162. Immunochemicals Sales Others , by Region K Units (2015-2020)
  • Table 163. Immunochemicals Sales: by Sales Channel(K Units)
  • Table 164. Immunochemicals Sales Direct Sales , by Region K Units (2015-2020)
  • Table 165. Immunochemicals Sales E-Commerce , by Region K Units (2015-2020)
  • Table 166. South America Immunochemicals Sales, by Country K Units (2015-2020)
  • Table 167. South America Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 168. South America Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 169. South America Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 170. South America Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 171. Brazil Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 172. Brazil Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 173. Brazil Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 174. Brazil Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 175. Argentina Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 176. Argentina Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 177. Argentina Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 178. Argentina Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 179. Rest of South America Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 180. Rest of South America Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 181. Rest of South America Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 182. Rest of South America Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 183. Asia Pacific Immunochemicals Sales, by Country K Units (2015-2020)
  • Table 184. Asia Pacific Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 185. Asia Pacific Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 186. Asia Pacific Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 187. Asia Pacific Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 188. China Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 189. China Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 190. China Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 191. China Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 192. Japan Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 193. Japan Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 194. Japan Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 195. Japan Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 196. India Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 197. India Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 198. India Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 199. India Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 200. South Korea Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 201. South Korea Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 202. South Korea Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 203. South Korea Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 204. Taiwan Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 205. Taiwan Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 206. Taiwan Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 207. Taiwan Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 208. Australia Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 209. Australia Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 210. Australia Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 211. Australia Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 212. Rest of Asia-Pacific Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 213. Rest of Asia-Pacific Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 214. Rest of Asia-Pacific Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 215. Rest of Asia-Pacific Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 216. Europe Immunochemicals Sales, by Country K Units (2015-2020)
  • Table 217. Europe Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 218. Europe Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 219. Europe Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 220. Europe Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 221. Germany Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 222. Germany Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 223. Germany Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 224. Germany Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 225. France Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 226. France Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 227. France Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 228. France Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 229. Italy Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 230. Italy Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 231. Italy Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 232. Italy Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 233. United Kingdom Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 234. United Kingdom Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 235. United Kingdom Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 236. United Kingdom Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 237. Netherlands Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 238. Netherlands Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 239. Netherlands Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 240. Netherlands Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 241. Rest of Europe Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 242. Rest of Europe Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 243. Rest of Europe Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 244. Rest of Europe Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 245. MEA Immunochemicals Sales, by Country K Units (2015-2020)
  • Table 246. MEA Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 247. MEA Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 248. MEA Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 249. MEA Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 250. Middle East Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 251. Middle East Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 252. Middle East Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 253. Middle East Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 254. Africa Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 255. Africa Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 256. Africa Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 257. Africa Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 258. North America Immunochemicals Sales, by Country K Units (2015-2020)
  • Table 259. North America Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 260. North America Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 261. North America Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 262. North America Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 263. United States Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 264. United States Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 265. United States Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 266. United States Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 267. Canada Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 268. Canada Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 269. Canada Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 270. Canada Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 271. Mexico Immunochemicals Sales, by Type K Units (2015-2020)
  • Table 272. Mexico Immunochemicals Sales, by Application K Units (2015-2020)
  • Table 273. Mexico Immunochemicals Sales, by Prodcuts K Units (2015-2020)
  • Table 274. Mexico Immunochemicals Sales, by Sales Channel K Units (2015-2020)
  • Table 275. Immunochemicals: by Type(USD/Units)
  • Table 276. Company Basic Information, Sales Area and Its Competitors
  • Table 277. Company Basic Information, Sales Area and Its Competitors
  • Table 278. Company Basic Information, Sales Area and Its Competitors
  • Table 279. Company Basic Information, Sales Area and Its Competitors
  • Table 280. Company Basic Information, Sales Area and Its Competitors
  • Table 281. Company Basic Information, Sales Area and Its Competitors
  • Table 282. Company Basic Information, Sales Area and Its Competitors
  • Table 283. Company Basic Information, Sales Area and Its Competitors
  • Table 284. Company Basic Information, Sales Area and Its Competitors
  • Table 285. Company Basic Information, Sales Area and Its Competitors
  • Table 286. Immunochemicals: by Type(USD Million)
  • Table 287. Immunochemicals Custom monoclonal antibodies , by Region USD Million (2021-2026)
  • Table 288. Immunochemicals Custom polyclonal antibodies , by Region USD Million (2021-2026)
  • Table 289. Immunochemicals Custom AB fragments , by Region USD Million (2021-2026)
  • Table 290. Immunochemicals Catalogue antibodies , by Region USD Million (2021-2026)
  • Table 291. Immunochemicals Others , by Region USD Million (2021-2026)
  • Table 292. Immunochemicals: by Application(USD Million)
  • Table 293. Immunochemicals Healthcare , by Region USD Million (2021-2026)
  • Table 294. Immunochemicals Environmental Science , by Region USD Million (2021-2026)
  • Table 295. Immunochemicals Crop Protection and Biotechnology , by Region USD Million (2021-2026)
  • Table 296. Immunochemicals Other , by Region USD Million (2021-2026)
  • Table 297. Immunochemicals: by Prodcuts(USD Million)
  • Table 298. Immunochemicals CD4 , by Region USD Million (2021-2026)
  • Table 299. Immunochemicals LEU3 , by Region USD Million (2021-2026)
  • Table 300. Immunochemicals CD8a , by Region USD Million (2021-2026)
  • Table 301. Immunochemicals CD44 , by Region USD Million (2021-2026)
  • Table 302. Immunochemicals Ly6g , by Region USD Million (2021-2026)
  • Table 303. Immunochemicals IFN Gamma , by Region USD Million (2021-2026)
  • Table 304. Immunochemicals CD69 , by Region USD Million (2021-2026)
  • Table 305. Immunochemicals CD19 , by Region USD Million (2021-2026)
  • Table 306. Immunochemicals FOXP3 , by Region USD Million (2021-2026)
  • Table 307. Immunochemicals CD14 , by Region USD Million (2021-2026)
  • Table 308. Immunochemicals EPCAM , by Region USD Million (2021-2026)
  • Table 309. Immunochemicals Ly5 , by Region USD Million (2021-2026)
  • Table 310. Immunochemicals Others , by Region USD Million (2021-2026)
  • Table 311. Immunochemicals: by Sales Channel(USD Million)
  • Table 312. Immunochemicals Direct Sales , by Region USD Million (2021-2026)
  • Table 313. Immunochemicals E-Commerce , by Region USD Million (2021-2026)
  • Table 314. South America Immunochemicals, by Country USD Million (2021-2026)
  • Table 315. South America Immunochemicals, by Type USD Million (2021-2026)
  • Table 316. South America Immunochemicals, by Application USD Million (2021-2026)
  • Table 317. South America Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 318. South America Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 319. Brazil Immunochemicals, by Type USD Million (2021-2026)
  • Table 320. Brazil Immunochemicals, by Application USD Million (2021-2026)
  • Table 321. Brazil Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 322. Brazil Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 323. Argentina Immunochemicals, by Type USD Million (2021-2026)
  • Table 324. Argentina Immunochemicals, by Application USD Million (2021-2026)
  • Table 325. Argentina Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 326. Argentina Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 327. Rest of South America Immunochemicals, by Type USD Million (2021-2026)
  • Table 328. Rest of South America Immunochemicals, by Application USD Million (2021-2026)
  • Table 329. Rest of South America Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 330. Rest of South America Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 331. Asia Pacific Immunochemicals, by Country USD Million (2021-2026)
  • Table 332. Asia Pacific Immunochemicals, by Type USD Million (2021-2026)
  • Table 333. Asia Pacific Immunochemicals, by Application USD Million (2021-2026)
  • Table 334. Asia Pacific Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 335. Asia Pacific Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 336. China Immunochemicals, by Type USD Million (2021-2026)
  • Table 337. China Immunochemicals, by Application USD Million (2021-2026)
  • Table 338. China Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 339. China Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 340. Japan Immunochemicals, by Type USD Million (2021-2026)
  • Table 341. Japan Immunochemicals, by Application USD Million (2021-2026)
  • Table 342. Japan Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 343. Japan Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 344. India Immunochemicals, by Type USD Million (2021-2026)
  • Table 345. India Immunochemicals, by Application USD Million (2021-2026)
  • Table 346. India Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 347. India Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 348. South Korea Immunochemicals, by Type USD Million (2021-2026)
  • Table 349. South Korea Immunochemicals, by Application USD Million (2021-2026)
  • Table 350. South Korea Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 351. South Korea Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 352. Taiwan Immunochemicals, by Type USD Million (2021-2026)
  • Table 353. Taiwan Immunochemicals, by Application USD Million (2021-2026)
  • Table 354. Taiwan Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 355. Taiwan Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 356. Australia Immunochemicals, by Type USD Million (2021-2026)
  • Table 357. Australia Immunochemicals, by Application USD Million (2021-2026)
  • Table 358. Australia Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 359. Australia Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 360. Rest of Asia-Pacific Immunochemicals, by Type USD Million (2021-2026)
  • Table 361. Rest of Asia-Pacific Immunochemicals, by Application USD Million (2021-2026)
  • Table 362. Rest of Asia-Pacific Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 363. Rest of Asia-Pacific Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 364. Europe Immunochemicals, by Country USD Million (2021-2026)
  • Table 365. Europe Immunochemicals, by Type USD Million (2021-2026)
  • Table 366. Europe Immunochemicals, by Application USD Million (2021-2026)
  • Table 367. Europe Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 368. Europe Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 369. Germany Immunochemicals, by Type USD Million (2021-2026)
  • Table 370. Germany Immunochemicals, by Application USD Million (2021-2026)
  • Table 371. Germany Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 372. Germany Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 373. France Immunochemicals, by Type USD Million (2021-2026)
  • Table 374. France Immunochemicals, by Application USD Million (2021-2026)
  • Table 375. France Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 376. France Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 377. Italy Immunochemicals, by Type USD Million (2021-2026)
  • Table 378. Italy Immunochemicals, by Application USD Million (2021-2026)
  • Table 379. Italy Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 380. Italy Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 381. United Kingdom Immunochemicals, by Type USD Million (2021-2026)
  • Table 382. United Kingdom Immunochemicals, by Application USD Million (2021-2026)
  • Table 383. United Kingdom Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 384. United Kingdom Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 385. Netherlands Immunochemicals, by Type USD Million (2021-2026)
  • Table 386. Netherlands Immunochemicals, by Application USD Million (2021-2026)
  • Table 387. Netherlands Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 388. Netherlands Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 389. Rest of Europe Immunochemicals, by Type USD Million (2021-2026)
  • Table 390. Rest of Europe Immunochemicals, by Application USD Million (2021-2026)
  • Table 391. Rest of Europe Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 392. Rest of Europe Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 393. MEA Immunochemicals, by Country USD Million (2021-2026)
  • Table 394. MEA Immunochemicals, by Type USD Million (2021-2026)
  • Table 395. MEA Immunochemicals, by Application USD Million (2021-2026)
  • Table 396. MEA Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 397. MEA Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 398. Middle East Immunochemicals, by Type USD Million (2021-2026)
  • Table 399. Middle East Immunochemicals, by Application USD Million (2021-2026)
  • Table 400. Middle East Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 401. Middle East Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 402. Africa Immunochemicals, by Type USD Million (2021-2026)
  • Table 403. Africa Immunochemicals, by Application USD Million (2021-2026)
  • Table 404. Africa Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 405. Africa Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 406. North America Immunochemicals, by Country USD Million (2021-2026)
  • Table 407. North America Immunochemicals, by Type USD Million (2021-2026)
  • Table 408. North America Immunochemicals, by Application USD Million (2021-2026)
  • Table 409. North America Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 410. North America Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 411. United States Immunochemicals, by Type USD Million (2021-2026)
  • Table 412. United States Immunochemicals, by Application USD Million (2021-2026)
  • Table 413. United States Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 414. United States Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 415. Canada Immunochemicals, by Type USD Million (2021-2026)
  • Table 416. Canada Immunochemicals, by Application USD Million (2021-2026)
  • Table 417. Canada Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 418. Canada Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 419. Mexico Immunochemicals, by Type USD Million (2021-2026)
  • Table 420. Mexico Immunochemicals, by Application USD Million (2021-2026)
  • Table 421. Mexico Immunochemicals, by Prodcuts USD Million (2021-2026)
  • Table 422. Mexico Immunochemicals, by Sales Channel USD Million (2021-2026)
  • Table 423. Immunochemicals Sales: by Type(K Units)
  • Table 424. Immunochemicals Sales Custom monoclonal antibodies , by Region K Units (2021-2026)
  • Table 425. Immunochemicals Sales Custom polyclonal antibodies , by Region K Units (2021-2026)
  • Table 426. Immunochemicals Sales Custom AB fragments , by Region K Units (2021-2026)
  • Table 427. Immunochemicals Sales Catalogue antibodies , by Region K Units (2021-2026)
  • Table 428. Immunochemicals Sales Others , by Region K Units (2021-2026)
  • Table 429. Immunochemicals Sales: by Application(K Units)
  • Table 430. Immunochemicals Sales Healthcare , by Region K Units (2021-2026)
  • Table 431. Immunochemicals Sales Environmental Science , by Region K Units (2021-2026)
  • Table 432. Immunochemicals Sales Crop Protection and Biotechnology , by Region K Units (2021-2026)
  • Table 433. Immunochemicals Sales Other , by Region K Units (2021-2026)
  • Table 434. Immunochemicals Sales: by Prodcuts(K Units)
  • Table 435. Immunochemicals Sales CD4 , by Region K Units (2021-2026)
  • Table 436. Immunochemicals Sales LEU3 , by Region K Units (2021-2026)
  • Table 437. Immunochemicals Sales CD8a , by Region K Units (2021-2026)
  • Table 438. Immunochemicals Sales CD44 , by Region K Units (2021-2026)
  • Table 439. Immunochemicals Sales Ly6g , by Region K Units (2021-2026)
  • Table 440. Immunochemicals Sales IFN Gamma , by Region K Units (2021-2026)
  • Table 441. Immunochemicals Sales CD69 , by Region K Units (2021-2026)
  • Table 442. Immunochemicals Sales CD19 , by Region K Units (2021-2026)
  • Table 443. Immunochemicals Sales FOXP3 , by Region K Units (2021-2026)
  • Table 444. Immunochemicals Sales CD14 , by Region K Units (2021-2026)
  • Table 445. Immunochemicals Sales EPCAM , by Region K Units (2021-2026)
  • Table 446. Immunochemicals Sales Ly5 , by Region K Units (2021-2026)
  • Table 447. Immunochemicals Sales Others , by Region K Units (2021-2026)
  • Table 448. Immunochemicals Sales: by Sales Channel(K Units)
  • Table 449. Immunochemicals Sales Direct Sales , by Region K Units (2021-2026)
  • Table 450. Immunochemicals Sales E-Commerce , by Region K Units (2021-2026)
  • Table 451. South America Immunochemicals Sales, by Country K Units (2021-2026)
  • Table 452. South America Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 453. South America Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 454. South America Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 455. South America Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 456. Brazil Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 457. Brazil Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 458. Brazil Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 459. Brazil Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 460. Argentina Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 461. Argentina Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 462. Argentina Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 463. Argentina Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 464. Rest of South America Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 465. Rest of South America Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 466. Rest of South America Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 467. Rest of South America Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 468. Asia Pacific Immunochemicals Sales, by Country K Units (2021-2026)
  • Table 469. Asia Pacific Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 470. Asia Pacific Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 471. Asia Pacific Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 472. Asia Pacific Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 473. China Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 474. China Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 475. China Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 476. China Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 477. Japan Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 478. Japan Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 479. Japan Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 480. Japan Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 481. India Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 482. India Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 483. India Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 484. India Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 485. South Korea Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 486. South Korea Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 487. South Korea Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 488. South Korea Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 489. Taiwan Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 490. Taiwan Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 491. Taiwan Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 492. Taiwan Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 493. Australia Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 494. Australia Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 495. Australia Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 496. Australia Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 497. Rest of Asia-Pacific Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 498. Rest of Asia-Pacific Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 499. Rest of Asia-Pacific Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 500. Rest of Asia-Pacific Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 501. Europe Immunochemicals Sales, by Country K Units (2021-2026)
  • Table 502. Europe Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 503. Europe Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 504. Europe Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 505. Europe Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 506. Germany Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 507. Germany Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 508. Germany Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 509. Germany Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 510. France Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 511. France Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 512. France Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 513. France Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 514. Italy Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 515. Italy Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 516. Italy Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 517. Italy Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 518. United Kingdom Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 519. United Kingdom Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 520. United Kingdom Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 521. United Kingdom Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 522. Netherlands Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 523. Netherlands Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 524. Netherlands Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 525. Netherlands Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 526. Rest of Europe Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 527. Rest of Europe Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 528. Rest of Europe Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 529. Rest of Europe Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 530. MEA Immunochemicals Sales, by Country K Units (2021-2026)
  • Table 531. MEA Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 532. MEA Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 533. MEA Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 534. MEA Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 535. Middle East Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 536. Middle East Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 537. Middle East Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 538. Middle East Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 539. Africa Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 540. Africa Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 541. Africa Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 542. Africa Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 543. North America Immunochemicals Sales, by Country K Units (2021-2026)
  • Table 544. North America Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 545. North America Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 546. North America Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 547. North America Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 548. United States Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 549. United States Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 550. United States Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 551. United States Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 552. Canada Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 553. Canada Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 554. Canada Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 555. Canada Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 556. Mexico Immunochemicals Sales, by Type K Units (2021-2026)
  • Table 557. Mexico Immunochemicals Sales, by Application K Units (2021-2026)
  • Table 558. Mexico Immunochemicals Sales, by Prodcuts K Units (2021-2026)
  • Table 559. Mexico Immunochemicals Sales, by Sales Channel K Units (2021-2026)
  • Table 560. Immunochemicals: by Type(USD/Units)
  • Table 561. Research Programs/Design for This Report
  • Table 562. Key Data Information from Secondary Sources
  • Table 563. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Immunochemicals: by Type USD Million (2015-2020)
  • Figure 5. Global Immunochemicals: by Application USD Million (2015-2020)
  • Figure 6. Global Immunochemicals: by Prodcuts USD Million (2015-2020)
  • Figure 7. Global Immunochemicals: by Sales Channel USD Million (2015-2020)
  • Figure 8. South America Immunochemicals Share (%), by Country
  • Figure 9. Asia Pacific Immunochemicals Share (%), by Country
  • Figure 10. Europe Immunochemicals Share (%), by Country
  • Figure 11. MEA Immunochemicals Share (%), by Country
  • Figure 12. North America Immunochemicals Share (%), by Country
  • Figure 13. Global Immunochemicals: by Type K Units (2015-2020)
  • Figure 14. Global Immunochemicals: by Application K Units (2015-2020)
  • Figure 15. Global Immunochemicals: by Prodcuts K Units (2015-2020)
  • Figure 16. Global Immunochemicals: by Sales Channel K Units (2015-2020)
  • Figure 17. South America Immunochemicals Share (%), by Country
  • Figure 18. Asia Pacific Immunochemicals Share (%), by Country
  • Figure 19. Europe Immunochemicals Share (%), by Country
  • Figure 20. MEA Immunochemicals Share (%), by Country
  • Figure 21. North America Immunochemicals Share (%), by Country
  • Figure 22. Global Immunochemicals: by Type USD/Units (2015-2020)
  • Figure 23. Global Immunochemicals share by Players 2020 (%)
  • Figure 24. Global Immunochemicals share by Players (Top 3) 2020(%)
  • Figure 25. Global Immunochemicals share by Players (Top 5) 2020(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 28. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
  • Figure 29. Abcam Plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. Abcam Plc. (United Kingdom) Revenue: by Geography 2020
  • Figure 31. Agilent Research Laboratories (United States Revenue, Net Income and Gross profit
  • Figure 32. Agilent Research Laboratories (United States Revenue: by Geography 2020
  • Figure 33. Roche Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. Roche Holding AG (Switzerland) Revenue: by Geography 2020
  • Figure 35. Otsuka Pharmaceutical (Japan) Revenue, Net Income and Gross profit
  • Figure 36. Otsuka Pharmaceutical (Japan) Revenue: by Geography 2020
  • Figure 37. Beckman Coulter GmbH (United States) Revenue, Net Income and Gross profit
  • Figure 38. Beckman Coulter GmbH (United States) Revenue: by Geography 2020
  • Figure 39. Biolegend, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Biolegend, Inc. (United States) Revenue: by Geography 2020
  • Figure 41. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 42. Bio-Rad Laboratories (United States) Revenue: by Geography 2020
  • Figure 43. Cell Signaling Technology (United States) Revenue, Net Income and Gross profit
  • Figure 44. Cell Signaling Technology (United States) Revenue: by Geography 2020
  • Figure 45. GenScript Biotech Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 46. GenScript Biotech Corporation (United States) Revenue: by Geography 2020
  • Figure 47. Global Immunochemicals: by Type USD Million (2021-2026)
  • Figure 48. Global Immunochemicals: by Application USD Million (2021-2026)
  • Figure 49. Global Immunochemicals: by Prodcuts USD Million (2021-2026)
  • Figure 50. Global Immunochemicals: by Sales Channel USD Million (2021-2026)
  • Figure 51. South America Immunochemicals Share (%), by Country
  • Figure 52. Asia Pacific Immunochemicals Share (%), by Country
  • Figure 53. Europe Immunochemicals Share (%), by Country
  • Figure 54. MEA Immunochemicals Share (%), by Country
  • Figure 55. North America Immunochemicals Share (%), by Country
  • Figure 56. Global Immunochemicals: by Type K Units (2021-2026)
  • Figure 57. Global Immunochemicals: by Application K Units (2021-2026)
  • Figure 58. Global Immunochemicals: by Prodcuts K Units (2021-2026)
  • Figure 59. Global Immunochemicals: by Sales Channel K Units (2021-2026)
  • Figure 60. South America Immunochemicals Share (%), by Country
  • Figure 61. Asia Pacific Immunochemicals Share (%), by Country
  • Figure 62. Europe Immunochemicals Share (%), by Country
  • Figure 63. MEA Immunochemicals Share (%), by Country
  • Figure 64. North America Immunochemicals Share (%), by Country
  • Figure 65. Global Immunochemicals: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific (United States)
  • Abcam Plc. (United Kingdom)
  • Agilent Research Laboratories (United States
  • Roche Holding AG (Switzerland)
  • Otsuka Pharmaceutical (Japan)
  • Beckman Coulter GmbH (United States)
  • Biolegend, Inc. (United States)
  • Bio-Rad Laboratories (United States)
  • Cell Signaling Technology (United States)
  • GenScript Biotech Corporation (United States)
Additional players considered in the study are as follows:
Cell Sciences (United States) , Lampire Biological Laboratories (United States) , ViroStat (United States) , PerkinElmer (United States) , Rockland Immunochemicals (United States) , Santa Cruz Biotechnology (United States) , Merck & Co (United States)
Select User Access Type

Key Highlights of Report


Jan 2022 221 Pages 76 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Immunochemicals Quantitative research analysis
Global Immunochemicals Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2016-2020; Base year: 2020; Forecast period: 2021 to 2026
Companies that are profiled in Global Immunochemicals Market are Thermo Fisher Scientific (United States), Abcam Plc. (United Kingdom), Agilent Research Laboratories (United States, Roche Holding AG (Switzerland), Otsuka Pharmaceutical (Japan), Beckman Coulter GmbH (United States), Biolegend, Inc. (United States), Bio-Rad Laboratories (United States), Cell Signaling Technology (United States) and GenScript Biotech Corporation (United States) etc.
Immunochemistry deals with the study of biochemical and molecular aspects of immunology, especially the character of antibodies, antigens and their interactions. Immunochemistry is the field of life sciences that examines the chemical reactions and components of the immune system. Immunochemicals find their usage in diagnostics, laboratory medicine, immunological reactions, and investigations as well as in the field of immunochemistry examination. Immunochemicals are used to study the reactions and components of the immune system and include growth factors, hormones, and their receptors, markers of metabolism, mono- and polyclonal antibodies, and antigens. Applications for immunochemical include antibody purification, isotyping, and fragmentation

Know More About Global Immunochemicals Report?

Have a Query? Click Here

Other Related Reports

Sheep Placenta Extract Comprehensive Study by Type (Sheep Placenta Extract Powders, Sheep Placenta Extract Fluids), Application (Dietary, Pharmaceutical, Cosmetics), Nature (Gluten-Free, Herbal, Hala...
$ 3450
DNA Sequencing Comprehensive Study by Type (Consumable, Instrument, Service), Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, Research, Treatme...
$ 3750
Agriculture Biotechnology Comprehensive Study by Type (Genome Editing Tools, Deoxy Ribonucleic Acid Sequencing, Ribonucleic Acid Interference, Synthetic Biology, Biochips), Application (Herbicide Tol...
$ 3800
Specific Pathogen Free Comprehensive Study by End Users (Research Institutes, Pharmaceutical Companies), Distribution Channels (Company Outlets, E-commerce Websites, Hypermarkets and Supermarkets, Po...
$ 3450
Polymers Drug Delivery Comprehensive Study by Type (Micelles, Microgels, Dendrimer, Hydrogels, Others), Application (Hospitals, Medical Research Center, Pharmaceutical Factory, Others), Formulations ...
$ 3650
Plant Activators Comprehensive Study by Type (Biological Plant Activators, Chemical Plant Activators), Application (Foliar Spray, Soil Treatment, Others), Forms (Solutions, Water-Dispersible & Water-...
$ 3450